These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 36208971)

  • 1. Functional analysis of RYR1 variants in patients with confirmed susceptibility to malignant hyperthermia.
    White R; Schiemann AH; Burling SM; Bjorksten A; Bulger T; Gillies R; Hopkins PM; Kamsteeg EJ; Machon RG; Massey S; Miller D; Perry M; Snoeck MMJ; Stephens J; Street N; van den Bersselaar LR; Stowell KM
    Br J Anaesth; 2022 Dec; 129(6):879-888. PubMed ID: 36208971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional characterisation of the R2452W ryanodine receptor variant associated with malignant hyperthermia susceptibility.
    Roesl C; Sato K; Schiemann A; Pollock N; Stowell KM
    Cell Calcium; 2014 Sep; 56(3):195-201. PubMed ID: 25086907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing the pathogenicity of RYR1 variants in malignant hyperthermia.
    Merritt A; Booms P; Shaw MA; Miller DM; Daly C; Bilmen JG; Stowell KM; Allen PD; Steele DS; Hopkins PM
    Br J Anaesth; 2017 Apr; 118(4):533-543. PubMed ID: 28403410
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and Functional Analysis of RYR1 Variants in a Family with a Suspected Myopathy and Associated Malignant Hyperthermia.
    Schiemann AH; Roesl C; Pollock N; Langton E; Bulger T; Stowell KM
    J Neuromuscul Dis; 2020; 7(1):51-60. PubMed ID: 31903994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional Characterization of C-terminal Ryanodine Receptor 1 Variants Associated with Central Core Disease or Malignant Hyperthermia.
    Parker R; Schiemann AH; Langton E; Bulger T; Pollock N; Bjorksten A; Gillies R; Hutchinson D; Roxburgh R; Stowell KM
    J Neuromuscul Dis; 2017; 4(2):147-158. PubMed ID: 28527222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Several Ryanodine Receptor Type 1 Gene Mutations of p.Arg2508 Are Potential Sources of Malignant Hyperthermia.
    Miyoshi H; Yasuda T; Otsuki S; Kondo T; Haraki T; Mukaida K; Nakamura R; Hamada H; Kawamoto M
    Anesth Analg; 2015 Oct; 121(4):994-1000. PubMed ID: 26381711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of ryanodine receptor-mediated calcium release in human B cells: relevance to diagnostic testing for malignant hyperthermia.
    McKinney LC; Butler T; Mullen SP; Klein MG
    Anesthesiology; 2006 Jun; 104(6):1191-201. PubMed ID: 16732090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional characterization of RYR1 variants identified in malignant hyperthermia susceptible individuals.
    Noda Y; Miyoshi H; Benucci S; Gonzalez A; Bandschapp O; Girard T; Treves S; Zorzato F
    Neuromuscul Disord; 2023 Dec; 33(12):951-963. PubMed ID: 37996280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BMI and malignant hyperthermia pathogenic ryanodine receptor type 1 sequence variants in Switzerland: A retrospective cohort analysis.
    Gonzalez A; Girard T; Dell-Kuster S; Urwyler A; Bandschapp O
    Eur J Anaesthesiol; 2021 Jul; 38(7):751-757. PubMed ID: 33259453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional characterization of the RYR1 mutation p.Arg4737Trp associated with susceptibility to malignant hyperthermia.
    Johannsen S; Treves S; Müller CR; Mögele S; Schneiderbanger D; Roewer N; Schuster F
    Neuromuscul Disord; 2016 Jan; 26(1):21-5. PubMed ID: 26631338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional properties of RYR1 mutations identified in Swedish patients with malignant hyperthermia and central core disease.
    Vukcevic M; Broman M; Islander G; Bodelsson M; Ranklev-Twetman E; Müller CR; Treves S
    Anesth Analg; 2010 Jul; 111(1):185-90. PubMed ID: 20142353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional studies of RYR1 mutations in the skeletal muscle ryanodine receptor using human RYR1 complementary DNA.
    Sato K; Pollock N; Stowell KM
    Anesthesiology; 2010 Jun; 112(6):1350-4. PubMed ID: 20461000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relevance of pathogenicity prediction tools in human RYR1 variants of unknown significance.
    Hoppe K; Jurkat-Rott K; Kranepuhl S; Wearing S; Heiderich S; Merlak S; Klingler W
    Sci Rep; 2021 Feb; 11(1):3445. PubMed ID: 33564012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A multi-dimensional analysis of genotype-phenotype discordance in malignant hyperthermia susceptibility.
    Ibarra Moreno CA; Kraeva N; Zvaritch E; Figueroa L; Rios E; Biesecker L; Van Petegem F; Hopkins PM; Riazi S
    Br J Anaesth; 2020 Dec; 125(6):995-1001. PubMed ID: 32861507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional characterization of 2 known ryanodine receptor mutations causing malignant hyperthermia.
    Schiemann AH; Paul N; Parker R; Pollock N; Bulger TF; Stowell KM
    Anesth Analg; 2014 Feb; 118(2):375-380. PubMed ID: 24361844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Remimazolam on Intracellular Calcium Dynamics in Myotubes Derived from Patients with Malignant Hyperthermia and Functional Analysis of Type 1 Ryanodine Receptor Gene Variants.
    Miyoshi H; Otsuki S; Mukaida K; Kido K; Sumii A; Ikeda T; Noda Y; Yasuda T; Narasaki S; Kato T; Kamiya S; Horikawa YT; Tsutsumi YM
    Genes (Basel); 2023 Oct; 14(11):. PubMed ID: 38002952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Updated variant curation expert panel criteria and pathogenicity classifications for 251 variants for RYR1-related malignant hyperthermia susceptibility.
    Johnston JJ; Dirksen RT; Girard T; Hopkins PM; Kraeva N; Ognoon M; Radenbaugh KB; Riazi S; Robinson RL; Saddic Iii LA; Sambuughin N; Saxena R; Shepherd S; Stowell K; Weber J; Yoo S; Rosenberg H; Biesecker LG
    Hum Mol Genet; 2022 Nov; 31(23):4087-4093. PubMed ID: 35849058
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Ile2453Thr mutation in the ryanodine receptor gene 1 is associated with facilitated calcium release from sarcoplasmic reticulum by 4-chloro-m-cresol in human myotubes.
    Wehner M; Rueffert H; Koenig F; Meinecke CD; Olthoff D
    Cell Calcium; 2003 Aug; 34(2):163-8. PubMed ID: 12810058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional analysis of
    Stephens J; Schiemann AH; Roesl C; Miller D; Massey S; Pollock N; Bulger T; Stowell K
    Temperature (Austin); 2016; 3(2):328-339. PubMed ID: 27857962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Next-generation DNA sequencing of a Swedish malignant hyperthermia cohort.
    Broman M; Kleinschnitz I; Bach JE; Rost S; Islander G; Müller CR
    Clin Genet; 2015 Oct; 88(4):381-5. PubMed ID: 25256590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.